Mrinal K. Ghosh

CN-6, Sector V, Salt Lake
Kolkata, WB 700091, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Targeting USP7 - a nano-therapeutic approach to restore and reactivate P53 for promoting apoptosis in glioma therapy.

Targeting USP7 - a nano-therapeutic approach to restore and reactivate P53 for promoting apoptosis in glioma therapy.

Journal: Nanomedicine (London, England)

Published: July 17, 2026

Dual PLGA nanoparticles co-encapsulating P5091 and Resveratrol synergistically target the USP7-MDM2-P53 axis for glioma therapy.

Dual PLGA nanoparticles co-encapsulating P5091 and Resveratrol synergistically target the USP7-MDM2-P53 axis for glioma therapy.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: February 18, 2026

STUB1 (CHIP) - a prognostic marker in cancer.

STUB1 (CHIP) - a prognostic marker in cancer.

Journal: Molecular omics

Published: November 19, 2025

Ubiquitin's code: UPS orchestrating DNA repair and genomic stability under genotoxic stress.

Ubiquitin's code: UPS orchestrating DNA repair and genomic stability under genotoxic stress.

Journal: Molecular and cellular biochemistry

Published: October 22, 2025

Isoquinolinone-Naphthoquinone Hybrids as Potent PARP-1 Inhibitors Induce Apoptosis in Glioma via DNA Damage and ROS Generation.

Isoquinolinone-Naphthoquinone Hybrids as Potent PARP-1 Inhibitors Induce Apoptosis in Glioma via DNA Damage and ROS Generation.

Journal: Journal of medicinal chemistry

Published: September 11, 2025

The Ability of Neonatal Mice to Develop Immunity to Mycobacterium tuberculosis Shows Sex Differences, with Females Displaying Evidence of an Enhanced Immune Response.

The Ability of Neonatal Mice to Develop Immunity to Mycobacterium tuberculosis Shows Sex Differences, with Females Displaying Evidence of an Enhanced Immune Response.

Journal: Journal of cellular immunology

Published: August 18, 2025

The Nuclear Face of PTEN: Implications in Cancer Prognosis and Targeted Therapy.

The Nuclear Face of PTEN: Implications in Cancer Prognosis and Targeted Therapy.

Journal: BioFactors (Oxford, England)

Published: June 12, 2025

CHIP modulates Wnt/β-catenin signalling in colorectal cancer through proteasomal degradation of DDX17.

CHIP modulates Wnt/β-catenin signalling in colorectal cancer through proteasomal degradation of DDX17.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: May 21, 2025

Identification of a novel p65-p68 loop: A crucial determinant for p68 gene regulation in oncogenesis.

Identification of a novel p65-p68 loop: A crucial determinant for p68 gene regulation in oncogenesis.

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms

Published: May 13, 2025

Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer.

Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer.

Journal: Epigenomics

Published: May 08, 2025

UPS and Kinases-Gatekeepers of the G1/S Transition.

UPS and Kinases-Gatekeepers of the G1/S Transition.

Journal: BioFactors (Oxford, England)

Published: January 03, 2025

CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy.

CK2: The master regulator in tumor immune-microenvironment - A crucial target in oncotherapy.

Journal: European journal of pharmacology

Published: November 13, 2024

Showing 1-12 of 76

Last Updated: 09/26/2026